BioCentury Grand Rounds Heads to Houston, Texas, for Its Sixth Meeting Designed to Connect Early-Stage Science with Today’s Investors and Executives

Registration is now open for BioCentury’s premier forum connecting academic innovators, biotech leaders, investors, and biopharma executives.

HOUSTON--(BUSINESS WIRE)--BioCentury is pleased to announce that registration is now open for the sixth edition of BioCentury Grand Rounds, taking place April 12–14, 2027, in Houston, Texas. The conference convenes academic innovators, biotech founders, biopharma leaders, and investors to bridge the gap between early-stage science and breakthrough new medicines. Registration, scientific poster nominations, and Presenting Company applications are now open.

“Houston is a leading center for medicine, research, and life sciences, with the talent and infrastructure to drive the future of medicine. Through our work with BioBridge, TMC Innovation partners, and TMC Venture Fund, we’ve seen the power of bringing visionary leaders together to advance new therapies and cures. We’re proud to bring BioCentury Grand Rounds to Houston and spotlight the innovation shaping the future of medicine here.” - William F. McKeon, President & CEO, Texas Medical Center

Grand Rounds: US has become a leading translational science forum, creating opportunities for collaboration across academia, industry, and investment. Through scientific poster presentations, panel discussions, and one-to-one partnering, delegates engage in rigorous debate that puts translational science, an often-overlooked topic, front and center to explore the discoveries, technologies and deals shaping the future of drug development.

“Grand Rounds represents BioCentury’s commitment to building global networks of scientists, drug finders, and smart investors. Together, they will solve translational bottlenecks and create the next wave of healthcare innovations,” said BioCentury Co-Founder and CEO David Flores. “When we created Grand Rounds, we knew it would fill a real need at the top of the biopharma value chain. This has been validated by the energy of these meetings in the U.S. and Europe. We know Houston will take this momentum to the next level.”

In 2027, BioCentury brings the conference to Texas, a state home to over 7,400 life sciences and biotech firms. The city of Houston plays an important role as well, as it is home to Grand Rounds: US Regional Host Texas Medical Center, the world’s largest medical complex and beacon of life science enterprises.

Take advantage of the early-bird registration rate and secure your seat at the table. Register here as a delegate, or explore additional options such as our Presenting Company Package, Academic Poster Presenter, and our special entrepreneur and investor rate.

ABOUT BIOCENTURY

BioCentury is a research-driven knowledge company that has helped biopharma executives and investors make business-critical decisions for more than 30 years. Through deep analysis, trusted reporting, and global convenings, BioCentury connects leaders across the innovation ecosystem to drive the translation of science into solutions.